In order to ascertain the potential pharmacological effects and determine the toxicological profile of a drug it is necessary to carry out animal (nonclinical) studies, the results of which will allow predicting the effects of a medicinal product in humans.

Our highly professional team plans and organises a broad spectrum of nonclinical studies both in the process of development of new molecules and for marketing authorisation of well-known drugs in accordance with the requirements of regulatory enactments and Good Laboratory Practice (GLP) guidelines.

We have accumulated extensive experience in pharmacologic profile and toxicology (acute, chronic toxicity, genotoxicity etc.) research.

Contacts:

Vadims Kisis
Head of Medical and Clinical Research Department
E-mail: vadims.kisis@olainfarm.com